MEDICALLY REVIEWED

FDA approves lenacapavir (Sunleca®) in heavily pre-treated adults with multi-drug resistant HIV-1 infection

Last medically reviewed on 13 Jan 2023

Lenacapavir (Sunleca®), a first-in-class long-acting HIV-1 capsid function inhibitor, was approved by the FDA in December 2022 . . .

Sign Up or Log In as a healthcare professional to read the full article.

Kaye

Kaye obtained her Masters of Pharmacy degree from the University College London and has spent the better part of her career as a clinical pharmacist in a tertiary care hospital. Her professional interests are centred on HEOR and HTA work, in hopes of ultimately influencing cost-effective decisions for patient care.

Also worth reading

People With Down Syndrome Face Higher Risk of Severe COVID-19

October 30, 2020

Title: People With Down Syndrome Face Higher Risk of Severe COVID-19
Category: Health News
Created: 10/27/2020 12:00:00 AM
Last Editorial Review: 10/28/2020 12:00:00 AM

Are Mothers-To-Be Ready for Prenatal Test Results?

August 3, 2022

Prenatal testing can show potential chromosomal defects and genetic disorders or diseases in infants. Learn more about its types

Sleep, Pain, Kidney Stones – Top Stories and Articles of 2021 for MCA

December 31, 2021

As we round off 2021 and welcome 2022, let’s recap and take a look at what are the top 5 articles that Medical Channel Asia

How To Relieve Neck Pain?

Most adults would have suffered from neck pain in one way or another. Find out some home remedies for neck pain, and what doctors can do as well.

July 4, 2022

World Braille Day 2023

Most of the current users of Braille are people who suffer from vision impairment or vision loss at a young age.

January 4, 2023

Claw Toes: Causes and Treatments

Claw toes are a medical condition in which the toes of the foot are curled up in a flexed position. Learn about its causes and treatments

September 2, 2022

MEDICAL CHANNEL ASIA

PUBLIC PORTAL

MEDICAL CHANNEL ASIA

PUBLIC PORTAL

MEDICALLY REVIEWED

FDA approves lenacapavir (Sunleca®) in heavily pre-treated adults with multi-drug resistant HIV-1 infection

Kaye

Also worth reading

People With Down Syndrome Face Higher Risk of Severe COVID-19

Are Mothers-To-Be Ready for Prenatal Test Results?

Sleep, Pain, Kidney Stones – Top Stories and Articles of 2021 for MCA

People also read:

How To Relieve Neck Pain?

World Braille Day 2023

Claw Toes: Causes and Treatments

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

About Us

Advertise

Contact Us

My Account

Privacy Policy

FOLLOW MCA

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

FOLLOW MCA

Copyright © Medical Channel Asia 2022. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.

PUBLIC PORTAL

PUBLIC PORTAL

MEDICALLY REVIEWED

FDA approves lenacapavir (Sunleca®) in heavily pre-treated adults with multi-drug resistant HIV-1 infection

Kaye

Share via

Also worth reading

People also read:

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

FOLLOW MCA

Looking for health news and information? Stay updated with MCA’s health articles!

By clicking Submit, I agree to receive health newsletters and updates on upcoming health events from Medical Channel Asia and its partners.

FOLLOW MCA

Copyright © Medical Channel Asia 2022. All rights reserved. The contents on Medical Channel Asia are for general educational purposes only. It is not intended to be a substitute for professional medical advice, treatment, or diagnosis. See additional information.

Copyright © Medical Channel Asia 2022. All rights reserved.
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.